Stay updated on ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial
Sign up to get notified when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.

Latest updates to the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a newer version of the study record.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the page; no study content appears to be altered.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page version was updated from v3.6.3 to v3.6.4, indicating a minor software update. There are no visible changes to the study details or layout resulting from this revision.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a version update of the page's underlying system. This is a maintenance change and does not modify the study details or other substantive content.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page shows a new Revision tag: v3.6.2, replacing the previous v3.6.0. This indicates a minor software or formatting update to the page rather than a change to the trial details.SummaryDifference0.0%

- Check92 days agoChange DetectedAdded a 'No longer looking for participants' notice indicating recruitment has closed. Introduced new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and updated header formatting (removal of the 'Intervention / Treatment' variant) along with a revision label change to Revision: v3.6.0 from v3.5.5.SummaryDifference0.4%

Stay in the know with updates to ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.